{
  "id": 374,
  "text": "Biological agents.IARC Monogr Eval Carcinog Risks Hum.100B:1–475.Available from: https://publications.iarc.fr/119 PMID:23189750 Islami F, Fedewa SA, Jemal A (2019).Trends in cervical cancer incidence rates by age, race/ethnicity, histolog­ ical subtype, and stage at diagnosis in the United States.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Biological agents.IARC Monogr Eval Carcinog Risks Hum.100B:1–475.Available from: https://publications.iarc.fr/119 PMID:23189750 Islami F, Fedewa SA, Jemal A (2019).Trends in cervical cancer incidence rates by age, race/ethnicity, histolog­ ical subtype, and stage at diagnosis in the United States.\n\n<question>: ",
  "ChatGPT_response_0": "生物制剂在癌症风险评估中扮演着重要的角色，对于女性子宫颈癌发病率的趋势变化，研究表明在美国，女性子宫颈癌的发病率在不同年龄组、种族/族裔、病理亚型和诊断阶段之间存在变化。这种变化可能受到多种因素的影响，包括生物制剂的使用。因此，了解生物制剂在女性子宫颈癌发病率方面的趋势变化对于评估和管理患者的风险至关重要。",
  "query": "生物制剂在癌症风险评估中扮演着重要的角色，您是否对其在女性子宫颈癌发病率中的趋势变化有所了解？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 生物制剂在癌症风险评估中扮演着重要的角色，您是否对其在女性子宫颈癌发病率中的趋势变化有所了解？\n\n<reference text>: Biological agents.IARC Monogr Eval Carcinog Risks Hum.100B:1–475.Available from: https://publications.iarc.fr/119 PMID:23189750 Islami F, Fedewa SA, Jemal A (2019).Trends in cervical cancer incidence rates by age, race/ethnicity, histolog­ ical subtype, and stage at diagnosis in the United States.\n\n<reply>: ",
  "response": "生物制剂在癌症风险评估中扮演着重要的角色，对于女性子宫颈癌发病率的趋势变化，研究表明在美国，女性子宫颈癌的发病率在不同年龄组、种族/族裔、病理亚型和诊断阶段之间存在变化。这种变化可能受到多种因素的影响，包括生物制剂的使用。因此，了解生物制剂在女性子宫颈癌发病率方面的趋势变化对于评估和管理患者的风险至关重要。"
}